3rd Circ. Urged To Revive Fosamax MDL
Fosamax patients have told the Third Circuit a lower court's decision to toss multidistrict litigation alleging Merck failed to warn of the osteoporosis drug's atypical femoral fracture risk is "riddled with...To view the full article, register now.
Already a subscriber? Click here to view full article